Zepbound on Good Hang with Amy Poehler

Jon Hamm

0:33
mid-roll
Amy Poehler
The Ringer
April 28, 2026
UnknownBrand awarenessBaked-in adHealthcare
0:00 / 0:33
@ 42:12 in ep

Estimated current placement value

Low confidence
~$12,000range $1,200$110,000

What a comparable one-episode placement on this show might cost today—not reported advertiser spend or a historical invoice.

How this estimate works

A broad audience range for the top 10 popularity tier is multiplied by public CPM benchmarks and a placement factor. Inputs for this read: 0:33 · Unknown · mid-roll.

Model placement-value-v1-2026-08 · benchmark inputs as of 2026-08
Methodology and limitations →

Transcript

Ask your doctor about Zepbound tirzepatite, the first and only FDA approved prescription medicine for moderate to severe obstructive sleep apnea, OSA, in adults with obesity. ZepBound is a prescription medicine used with a reduced calorie diet and increased physical activity to help adults with moderate to severe obstructive sleep apnea, OSA, and obesity to improve their OSA. ZepBound is approved as a two point five, five, seven point five, ten, twelve point five, or fifteen milligram injection.

Auto-transcribed · verbatim audio matches · Report an error

Episode

Good Hang with Amy Poehler
Jon Hamm
Host: Amy Poehler
Publisher: The Ringer